Home

Clinical Trials

-Print This Page

Allergy & Asthma Network Mothers of Asthmatics (AANMA) maintains a listing of clinical research trials for adults and children with asthma and allergies. Check back frequently for new clinical trials in your area.

Note: AANMA does not endorse any company or product on this list. If you’re interested in participating in a clinical trial, we advise you to talk with your physician first. Please do not contact AANMA with questions about a clinical trial posted on this site; call the phone number listed in the specific study instead.

If you are an AANMA Professional Member and have an IRB-approved clinical trial you would like AANMA to post, contact us. If you are not a Professional Member, click here to join today!

VACCINES AND MEDICATIONS IN PREGNANCY SURVEILLANCE SYSTEM (VAMPSS)

Purpose of the study
This is an observational surveillance study to evaluate pregnancy outcomes in pregnant women who have taken asthma medications or received influenza vaccine during pregnancy. In one arm of the study, performed by the Organization of Teratology Information Specialists (OTIS), participants will take part in a telephone interview each trimester and after delivery. No clinic visits are required. VAMPSS is coordinated by the American Academy of Allergy Asthma & Immunology (AAAAI).

Eligible participants
·     Women who are pregnant AND
·     Who have taken a long-acting beta agonist (Foradil, Serevent, Advair, Dulera, Symbicort) or short-acting beta agonist (e.g. albuterol) or received influenza vaccine anytime in pregnancy

Principal investigator
Christina Chambers, PhD, MPH
University of California San Diego, San Diego, CA

For more information or to enroll
Call 877-311-8972
Visit www.otispregnancy.org/asthma-study-s13335

 


 


 

 

 

EXPECT Pregnancy Registry: An Observational Research Study of the Use and Safety of XOLAIR® (Omalizumab) During Pregnancy

Purpose of the study
This is an observational Pregnancy Registry to evaluate pregnancy outcomes in pregnant women who have taken XOLAIR before and/or during pregnancy. Participants will take part in a telephone interview each trimester, at the time of delivery, and when the baby turns 1 year old. No clinic visits are required. Mothers who continue to take XOLAIR while breastfeeding will be asked to participate in one more telephone interview when the baby is 18 months old. Eligible participants will be compensated for each telephone interview.

You do not have to be taking XOLAIR currently to enroll!

Eligible participants

  • Women who are pregnant AND
  • Who have received Xolair before or during pregnancy

Principal investigator
John M. Thorp Jr., MD
University of North Carolina at Chapel Hill

For more information or to enroll
Call 866-4XOLAIR (496-5247), option 3
Visit www.xolairpregnancyregistry.com

 


 


 

 

ALLERGY RESEARCH STUDY



Ages 6 – 11 with Perennial Allergic Rhinitis


Does your child have year-round allergy symptoms caused by dust mites or a pet in your home? Consider participating in an allergy research study testing an investigational drug.

Eligible participants

  • Ages 6 to 11
  • Year-round allergy symptoms caused by dust mites or a pet in your home

There will be 4 office visits over approximately a one-month period. Qualified volunteers receive study-related drug and related testing at no cost and compensation up to $240 for time and travel.

Sterling IRB – approved study at Clinical Research Institute, Plymouth, MN

Principal investigator
Philip C. Halverson, MD

For more information regarding this study
Contact Clinical Research Institute 612-333-2200 ext. 5
Visit  www.criminnesota.com

 


 


 

 

ASTHMA RESEARCH STUDY




Ages 18 – 75 with moderate persistent asthma

Eligible participants

  • Ages 18 to 75 years
  • Diagnosis of asthma
  • Currently using an inhaled steroid to treat asthma
  • Non-smokers or ex-smokers

The study will consist of 8 office visits over 24 weeks. Qualified volunteers will receive investigational drug and study-related testing at no cost and compensation for participation.

Chesapeake IRB – approved trial at Clinical Research Institute, Minneapolis, MN

Principal investigator 
Gary D. Berman, MD

For more information regarding this study
Contact Clinical Research Institute 612-333-2200 ext. 5, or visit www.criminnesota.com